Skip to main content
CNS Neuroscience & Therapeutics logoLink to CNS Neuroscience & Therapeutics
. 2020 May 27;26(7):778. doi: 10.1111/cns.13393

Retraction: Effect of Fasudil on remyelination following cuprizone‐induced demyelination.

Jing Wang 1, Ruo‐Xuan Sui 2, Qiang Miao 2, Qing Wang 2, Li‐Juan Song 2, Jie‐Zhong Yu 3, Yan‐Hua Li 3, Bao‐Guo Xiao 4,, Cun‐Gen Ma 1,2,3,
PMCID: PMC7298976  PMID: 32462797

Abstract

Retraction: Wang J, Sui R‐X, Miao Q, et al. Effect of Fasudil on remyelination following cuprizone‐induced demyelination. CNS Neuroscience & Therapeutics, 2020;26:76–89. https://doi.org/10.1111/cns.13154. The above article published online on May 23, 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Professor Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to major overlap with a previously published article from the same group of authors.


Retraction: Wang J, Sui R‐X, Miao Q, et al. Effect of Fasudil on remyelination following cuprizone‐induced demyelination. CNS Neuroscience & Therapeutics, 2020;26:76–89. https://doi.org/10.1111/cns.13154. The above article published online on May 23, 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Professor Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to major overlap with a previously published article from the same group of authors.

Contributor Information

Bao‐Guo Xiao, Email: bgxiao@shmu.edu.cn.

Cun‐Gen Ma, Email: macungen2001@163.com.


Articles from CNS Neuroscience & Therapeutics are provided here courtesy of Wiley

RESOURCES